| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
|
Freedman, O. C.
|
|
2009
|
119 |
1 |
p. 155-161
|
artikel
|
| 2 |
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence
|
Pentheroudakis, George
|
|
2009
|
119 |
1 |
p. 1-11
|
artikel
|
| 3 |
Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials
|
Kyrgidis, Athanassios
|
|
2009
|
119 |
1 |
p. 253-254
|
artikel
|
| 4 |
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms
|
Jakubowska, Anna
|
|
2009
|
119 |
1 |
p. 201-211
|
artikel
|
| 5 |
Breast cancer-related preferences among women with and without BRCA mutations
|
Grann, Victor R.
|
|
2009
|
119 |
1 |
p. 177-184
|
artikel
|
| 6 |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers
|
Palanca Suela, Sarai
|
|
2009
|
119 |
1 |
p. 87-93
|
artikel
|
| 7 |
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
|
Tomova, Antoaneta
|
|
2009
|
119 |
1 |
p. 169-176
|
artikel
|
| 8 |
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
|
Ronde, Jorma J. de
|
|
2009
|
119 |
1 |
p. 119-126
|
artikel
|
| 9 |
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines
|
Karnan, Sivasundaram
|
|
2009
|
119 |
1 |
p. 249-251
|
artikel
|
| 10 |
Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma?
|
Lim, Hye In
|
|
2009
|
119 |
1 |
p. 163-167
|
artikel
|
| 11 |
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
|
Khan, Qamar J.
|
|
2009
|
119 |
1 |
p. 111-118
|
artikel
|
| 12 |
Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer
|
Pal, Sumanta K.
|
|
2009
|
119 |
1 |
p. 25-32
|
artikel
|
| 13 |
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database
|
Brinton, Louise A.
|
|
2009
|
119 |
1 |
p. 185-192
|
artikel
|
| 14 |
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth
|
Zhao, Jieying
|
|
2009
|
119 |
1 |
p. 39-51
|
artikel
|
| 15 |
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)
|
Polyzos, Aristides
|
|
2009
|
119 |
1 |
p. 95-104
|
artikel
|
| 16 |
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
|
Garwood, Elisabeth R.
|
|
2009
|
119 |
1 |
p. 137-144
|
artikel
|
| 17 |
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
|
Giordano, Cinzia
|
|
2009
|
119 |
1 |
p. 71-85
|
artikel
|
| 18 |
Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1
|
Pettigrew, Christopher A.
|
|
2008
|
119 |
1 |
p. 239-247
|
artikel
|
| 19 |
Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families
|
Konecny, Michal
|
|
2008
|
119 |
1 |
p. 233-237
|
artikel
|
| 20 |
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
|
Ramón y Cajal, T.
|
|
2009
|
119 |
1 |
p. 33-38
|
artikel
|
| 21 |
Pain perception and detailed visual pain mapping in breast cancer survivors
|
Jud, Sebastian M.
|
|
2009
|
119 |
1 |
p. 105-110
|
artikel
|
| 22 |
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
|
Milne, Roger L.
|
|
2009
|
119 |
1 |
p. 221-232
|
artikel
|
| 23 |
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients
|
Liu, Shuzhen
|
|
2009
|
119 |
1 |
p. 53-61
|
artikel
|
| 24 |
Prognosis of BRCA-associated breast cancer: a summary of evidence
|
Bordeleau, L.
|
|
2009
|
119 |
1 |
p. 13-24
|
artikel
|
| 25 |
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
|
Inoue, Kenichi
|
|
2009
|
119 |
1 |
p. 127-136
|
artikel
|
| 26 |
Regulation of αB-crystallin gene expression by the transcription factor Ets1 in breast cancer
|
Bosman, Joshua D.
|
|
2009
|
119 |
1 |
p. 63-70
|
artikel
|
| 27 |
Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer
|
Han, Wonshik
|
|
2009
|
119 |
1 |
p. 193-200
|
artikel
|
| 28 |
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
|
Azambuja, Evandro de
|
|
2009
|
119 |
1 |
p. 145-153
|
artikel
|
| 29 |
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis
|
Mujahid, Mahasin S.
|
|
2009
|
119 |
1 |
p. 213-220
|
artikel
|
Tijdschrift beschrijving